뒤로
Biontech SE(BNTX) 가격
BNTX 주가 차트
BNTX 수입
Biontech SE
$109
2.76%
$2.93
종가: Jan 16, 16:00:00 GMT-5
$109.03
0.02%
$0.03
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$106.07
시가
$109.24
일일 범위
$107.91 - $111.26
52주 범위
$81.2 - $126.77
거래량
1.1M
평균 거래량
1.0M
EPS(TTM)
-2.36
배당수익률
0.00%
시가총액
$26.2B
BNTX란 무엇인가요?
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. The company is headquartered in Mainz, Rheinland-Pfalz and currently employs 6,772 full-time employees. The company went IPO on 2019-10-10. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The firm is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. The company also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.